Guru Ownership Trend
Guru Analysis for Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (FOLD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $152.25 M.
Top institutional holders include George Soros and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.61 M net outflow during the quarter.
Recent activity highlights Jeremy Grantham who opened a new position. Conversely, Steven Cohen reduced exposure by 97.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Amicus Therapeutics, Inc. (FOLD)
Major holders include George Soros ($83.19 M), Renaissance Technologies (RenTech) ($27.08 M), Jeremy Grantham ($13.61 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 10.51 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.61 M, with 5 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 2 fully exited FOLD. The total reported sell value was $36.72 M.
Yes, 3 managers opened new positions in FOLD, and 2 increased their existing holdings. The total reported buy value was $35.11 M.
